Envista Holdings Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 29, 2023
November 01, 2023 at 04:24 pm EDT
Share
Envista Holdings Corporation reported earnings results for the third quarter and nine months ended September 29, 2023. For the third quarter, the company reported sales was USD 631.3 million compared to USD 631.1 million a year ago. Net income was USD 21.5 million compared to USD 47.6 million a year ago. Basic earnings per share from continuing operations was USD 0.13 compared to USD 0.3 a year ago. Diluted earnings per share from continuing operations was USD 0.12 compared to USD 0.28 a year ago. Basic earnings per share was USD 0.13 compared to USD 0.29 a year ago. Diluted earnings per share was USD 0.12 compared to USD 0.27 a year ago.
For the nine months, sales was USD 1,920.9 million compared to USD 1,908.3 million a year ago. Net income was USD 117.2 million compared to USD 169.6 million a year ago. Basic earnings per share from continuing operations was USD 0.71 compared to USD 1.01 a year ago. Diluted earnings per share from continuing operations was USD 0.66 compared to USD 0.92 a year ago. Basic earnings per share was USD 0.71 compared to USD 1.04 a year ago. Diluted earnings per share was USD 0.66 compared to USD 0.95 a year ago.
Envista Holdings Corporation is a dental products company. The Company provides dental consumables, solutions, technology, and services. It has approximately 30 dental brands, including Nobel Biocare, Ormco and Kerr united. The Company operates through two segments: Specialty Products & Technologies and Equipment & Consumables. The Specialty Products & Technologies segment develops, manufactures, and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners, and lab products. The Equipment & Consumables segment develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems, and endodontic systems and related products; restorative materials, rotary burs, impression materials, bonding agents and cements, and infection prevention products.